← FDA DRUG APPROVALS

FDA ANDA · ANDA040317

DICYCLOMINE HYDROCHLORIDE

Sponsor: AUROBINDO PHARMA USA

APPLICATION
ANDA040317
TYPE
ANDA
ORIGINAL APPROVAL
1999-09-07
LATEST ACTION
2013-04-30
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

DICYCLOMINE HYDROCHLORIDEPrescription
DICYCLOMINE HYDROCHLORIDE 20MG · TABLET · ORAL

Approval history

2013-04-30Labeling · Supplement 11 · standardAP
2012-12-28Labeling · Supplement 10 · standardAP
2007-11-30Labeling · Supplement 5AP
2002-12-12Manufacturing (CMC) · Supplement 2AP
1999-12-22Labeling · Supplement 1AP
1999-09-07OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →